Isoproterenol mechanisms in inducing myocardial fibrosis and its application as an experimental model for the evaluation of therapeutic potential of phytochemicals and pharmaceuticals
Open Access
- 17 December 2024
- journal article
- research article
- Published by Wiley in Animal Models and Experimental Medicine
- Vol. 8 (1) , 67-91
Abstract
Cardiac injury initiates repair mechanisms and results in cardiac remodeling and fibrosis, which appears to be a leading cause of cardiovascular diseases. Cardiac fibrosis is characterized by the accumulation of extracellular matrix proteins, mainly collagen in the cardiac interstitium. Many experimental studies have demonstrated that fibrotic injury in the heart is reversible; therefore, it is vital to understand different molecular mechanisms that are involved in the initiation, progression, and resolution of cardiac fibrosis to enable the development of antifibrotic agents. Of the many experimental models, one of the recent models that has gained renewed interest is isoproterenol (ISP)–induced cardiac fibrosis. ISP is a synthetic catecholamine, sympathomimetic, and nonselective β‐adrenergic receptor agonist. The overstimulated and sustained activation of β‐adrenergic receptors has been reported to induce biochemical and physiological alterations and ultimately result in cardiac remodeling. ISP has been used for decades to induce acute myocardial infarction. However, the use of low doses and chronic administration of ISP have been shown to induce cardiac fibrosis; this practice has increased in recent years. Intraperitoneal or subcutaneous ISP has been widely used in preclinical studies to induce cardiac remodeling manifested by fibrosis and hypertrophy. The induced oxidative stress with subsequent perturbations in cellular signaling cascades through triggering the release of free radicals is considered the initiating mechanism of myocardial fibrosis. ISP is consistently used to induce fibrosis in laboratory animals and in cardiomyocytes isolated from animals. In recent years, numerous phytochemicals and synthetic molecules have been evaluated in ISP‐induced cardiac fibrosis. The present review exclusively provides a comprehensive summary of the pathological biochemical, histological, and molecular mechanisms of ISP in inducing cardiac fibrosis and hypertrophy. It also summarizes the application of this experimental model in the therapeutic evaluation of natural as well as synthetic compounds to demonstrate their potential in mitigating myocardial fibrosis and hypertrophy.Keywords
Funding Information
- United Arab Emirates University (12R104, 12R121)
This publication has 189 references indexed in Scilit:
- C188‐9 reduces TGF‐β1‐induced fibroblast activation and alleviates ISO‐induced cardiac fibrosis in miceFEBS Open Bio, 2021
- Cardiac response to adrenergic stress differs by sex and across the lifespanGeroScience, 2021
- Nur77 deficiency exacerbates cardiac fibrosis after myocardial infarction by promoting endothelial‐to‐mesenchymal transitionJournal of Cellular Physiology, 2020
- Crocin attenuates isoprenaline-induced myocardial fibrosis by targeting TLR4/NF-κB signaling: connecting oxidative stress, inflammation, and apoptosisNaunyn-Schmiedeberg's Archives of Pharmacology, 2019
- Inflammation and fibrosis in murine models of heart failureBasic Research in Cardiology, 2019
- Isoproterenol‐induced cardiac ischemia and fibrosis: Plant‐based approaches for interventionPhytotherapy Research, 2018
- Isoproterenol-Induced Heart Failure Mouse Model Using Osmotic Pump Implantation2018
- Relevance of mouse models of cardiac fibrosis and hypertrophy in cardiac researchMolecular and Cellular Biochemistry, 2016
- Oligomerized grape seed proanthocyanidins ameliorates isoproterenol‐induced cardiac remodeling in rats: role of oxidative stressPhytotherapy Research, 2010
- Effect of U50,488H, a κ-opioid receptor agonist on myocardial α-and β-myosin heavy chain expression and oxidative stress associated with isoproterenol-induced cardiac hypertrophy in ratMolecular and Cellular Biochemistry, 2010